When is it appropriate to treat children with social anxiety, pharmacologically?

References

• American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). Arlington, VA: American Psychiatric Pub; 2013.
   Google Scholar
• Stein DJ, Lim CC, Roest AM, et al. The cross-national epidemiology of social anxiety disorder: data from the world mental health survey initiative. BMC Med. 2017;15(1):143.
   PubMed Web of Science ®Google Scholar
• Patel DR, Feucht C, Brown K, et al. Pharmacological treatment of anxiety disorders in children and adolescents: a review for practitioners. Transl Pediatr. 2018;7(1):23.
   PubMed Web of Science ®Google Scholar
• Fehm L, Beesdo K, Jacobi F, et al. Social anxiety disorder above and below the diagnostic threshold: prevalence, comorbidity and impairment in the general population. Soc Psychiatry Psychiatr Epidemiol. 2008;43(4):257–265.
   PubMed Web of Science ®Google Scholar
• Heimberg RG. Cognitive-behavioral therapy for social anxiety disorder: current status and future directions. Biol Psychiatry. 2002;51(1):101–108.
   PubMed Web of Science ®Google Scholar
• Hofmann SG, Asnaani A, Vonk JJ, et al. The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cognitive Therapy Res. 2012;36(5):427–440.
   PubMed Web of Science ®Google Scholar
• Leigh E, Creswell C, Stallard P, et al. Delivering cognitive therapy for adolescent social anxiety disorder in NHS CAMHS: a clinical and cost analysis. Behav Cogn Psychother. 2021;1–13. DOI:https://doi.org/10.1017/S1352465821000035
   Google Scholar
• Heimberg RG, Hofmann SG, Liebowitz MR, et al. Social anxiety disorder in DSM-5. Depress Anxiety. 2014;31(6):472–479.
   PubMed Web of Science ®Google Scholar
• Scaini S, Belotti R, Ogliari A, et al. A comprehensive meta-analysis of cognitive-behavioral interventions for social anxiety disorder in children and adolescents. J Anxiety Disord. 2016;42:105–112.
   PubMed Web of Science ®Google Scholar
• Wehry AM, Beesdo-Baum K, Hennelly MM, et al. Assessment and treatment of anxiety disorders in children and adolescents. Curr Psychiatry Rep. 2015;17(7):52.
   PubMed Web of Science ®Google Scholar
• Walkup JT, Albano AM, Piacentini J, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med. 2008;359(26):2753–2766. [PubMed: 18974308]
   PubMed Web of Science ®Google Scholar
• Wagner KD, Berard R, Stein MB, et al. A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder. Arch Gen Psychiatry. 2004;61(11):1153–1162.
   PubMed Web of Science ®Google Scholar
• Walkup JT, Labellarte MJ, Riddle MA, Research Unit on Pediatric Psychopharmacology Anxiety Study Group. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N Engl J Med. 2001;344(17):1279–1285.
   PubMed Web of Science ®Google Scholar
• March JS, Entusah AR, Rynn M, et al. A randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder. Biol Psychiatry. 2007;62(10):1149–1154.
   PubMed Web of Science ®Google Scholar
• Hussain FS, Dobson ET, Strawn JR. Pharmacologic treatment of pediatric anxiety disorders. Curr Treat Options Psychiatry. 2016;3(2):151–160.
   PubMedGoogle Scholar
• Murphy TK, Segarra A, Storch EA, et al. SSRI adverse events: how to monitor and manage. Int Rev Psychiatry. 2008;20(2):203–208.
   PubMed Web of Science ®Google Scholar
• Strawn JR, Welge JA, Wehry AM, et al. Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis. Depress Anxiety. 2015;32(3):149–157.
   PubMed Web of Science ®Google Scholar
• Strawn JR, Mills JA, Sauley BA, et al. The impact of antidepressant dose and class on treatment response in pediatric anxiety disorders: a meta-analysis. J Am Acad Child Adolesc Psychiatry. 2018;57(4):235–244.e232.
   PubMed Web of Science ®Google Scholar
• Witek MW, Rojas V, Alonso C, et al. Review of benzodiazepine use in children and adolescents. Psychiatr Q. 2005;76(3):283–296.
   PubMed Web of Science ®Google Scholar
• Strawn JR, Mills JA, Cornwall GJ, et al. Buspirone in children and adolescents with anxiety: a review and Bayesian analysis of abandoned randomized controlled trials. J Child Adolesc Psychopharmacol. 2018;28(1):2–9.
   PubMed Web of Science ®Google Scholar
• Kuang H, Johnson JA, Mulqueen JM, et al. The efficacy of benzodiazepines as acute anxiolytics in children: a meta-analysis. Depress Anxiety. 2017;34(10):888–896.
   PubMed Web of Science ®Google Scholar
• Connolly SD, Bernstein GA. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2007;46(2):267–283.
   PubMed Web of Science ®Google Scholar
• Tandt H, Audenaert K, Van Heeringen C. SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children. Tijdschr Psychiatr. 2009;51(6):387–393.
   PubMedGoogle Scholar
• Ferguson JM. SSRI antidepressant medications: adverse effects and tolerability. Prim Care Companion J Clin Psychiatry. 2001;3(1). DOI:https://doi.org/10.4088/PCC.v03n0105
   Google Scholar
• Wang Z, Whiteside SP, Sim L, et al. Comparative effectiveness and safety of cognitive behavioral therapy and pharmacotherapy for childhood anxiety disorders: a systematic review and meta-analysis. JAMA Pediatr. 2017;171(11):1049–1056.
   PubMed Web of Science ®Google Scholar
• Chavira DA, Stein MB, Bailey K, et al. Parental opinions regarding treatment for social anxiety disorder in youth. J Dev Behav Pediatr. 2003;24(5):315–322.
   PubMed Web of Science ®Google Scholar
• Goodwin R, Gould MS, Blanco C, et al. Prescription of psychotropic medications to youths in office-based practice. Psychiatric Serv. 2001;52(8):1081–1087.
   PubMed Web of Science ®Google Scholar